BENJAMIN KUNZE: Open Payments
NPI 1912301334 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 10 payments from 7 companies in 2025. Trend: 2023 $139 · 2024 $111 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $82 |
| Astellas Pharma US Inc | 2 | $44 |
| Legend Biotech USA Inc. | 1 | $23 |
| Ethicon US, LLC | 1 | $22 |
| Antares Pharma, Inc. | 1 | $21 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $19 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
Products named: Cresemba, LithoVue, AMS 700, Tria Firm, CARVYKTI, Echelon; Endopath, XYOSTED, PYLARIFY.
Industry payments across TX — which companies pay providers there.
